| Glenrock Family Dental | |
|
925 W Birch Street Glenrock WY 82637 | |
| (307) 436-8770 | |
| (307) 436-8771 |
| Full Name | Glenrock Family Dental |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 925 W Birch Street, Glenrock, Wyoming |
| Authorized Official Name and Position | Aaron D Larsen (OWNER) |
| Authorized Official Contact | 3074368770 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Glenrock Family Dental Po Box 2320 Glenrock WY 82637-2320 Ph: (307) 436-8770 | Glenrock Family Dental 925 W Birch Street Glenrock WY 82637 Ph: (307) 436-8770 |
| NPI Number | 1922470293 |
|---|---|
| Provider Enumeration Date | 10/27/2015 |
| Last Update Date | 10/27/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922470293 | NPI | - | NPPES |
| 131751200 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 1278 (Wyoming) | Primary |
News Archive
According to Millennium Research Group, the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016, driven largely by an aging population in the United States that will suffer an increasing incidence of conditions such as stroke, cerebral aneurysms and intracranial atherosclerosis disease.
The U.S. Food and Drug Administration today announced that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine).
The last large H1N1 influenza vaccination clinic for the 2009 flu season has been scheduled by the Macomb County Health Department. It is free of charge and will take place next Monday, Dec. 28, at Bethesda Christian Church in Sterling Heights from 10 a.m. to 3 p.m. Everyone over 6 months of age can receive the vaccine at this clinic.
The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.
BD Medical, a segment of BD, today announced the launch of the BD Hyflow™ needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
› Verified 2 days ago